Gyre Therapeutics (GYRE) Raw Materials (2022 - 2026)
Gyre Therapeutics (GYRE) posted Raw Materials of $774,000 for Q2 2026, down 35.9% from $1.21 million a year earlier and down 34.1% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Raw Materials (2022 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics' Raw Materials came in at $970,000, up 22.2% from FY2024.
- Annual Raw Materials shows a three-year compound annual growth rate of -2.8% (FY2022 to FY2025).
- In prior years, Gyre Therapeutics' Raw Materials was $794,000 in FY2024 (-13.6%), $919,000 in FY2023 (-13.0%) and $1.06 million in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Raw Materials since Q1 2024.
- On a year-over-year basis, Raw Materials increased in five of the last seven quarters, with growth averaging 6.2%.
- The strongest year-over-year quarter for Raw Materials in the past five years was Q1 2025, with growth of 61.5%; the weakest was Q2 2026, with a decline of 35.9%.
- According to Business Quant data, Raw Materials for the three prior quarters was $1.17 million (Q1 2026), $970,000 (Q4 2025) and $1.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 774,000.00 |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 970,000.00 |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 794,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 724,000.00 |
| Dec 31, 2023 | 919,000.00 |
| Dec 31, 2022 | 1.06 Mn |
API Access
Gyre Therapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();